Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
338 studies found for:    "Acne Vulgaris"
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne
Conditions: Acne Vulgaris;   Acne;   Propionibacterium Acnes
Intervention: Drug: MBI 226 Acne Solutions
2 Completed Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
Conditions: Acne Vulgaris;   Acne;   Propionibacterium Acnes
Intervention: Drug: MBI 226 Acne Solutions
3 Completed Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris
Condition: Acne Vulgaris
Intervention:
4 Recruiting Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment
Conditions: Acne Vulgaris;   Isotretinoin
Intervention:
5 Completed Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Placebo;   Drug: gevokizumab
6 Completed Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
Condition: Acne Vulgaris
Interventions: Drug: skinoren;   Drug: differin
7 Withdrawn Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: 5-ALA with Blu-U Light;   Drug: 5-ALA with Candela V-beam Pulse Dye Laser
8 Completed Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Epiduo Gel;   Drug: Duac Gel
9 Completed A Long Term Study of GK530G in Subjects With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: GK530G
10 Completed Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
Condition: Acne Vulgaris
Intervention: Drug: Topical Minocycline Foam FXFM244
11 Not yet recruiting CD5789 Long Term Safety Study on Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: CD5789
12 Completed Pulsed Dye Laser Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Fixed combination of clindamycin 1% + benzoyl peroxide 5%;   Device: Pulsed dye laser
13 Completed Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Clindamycin Phosphate / Benzoyl Peroxide Gel;   Drug: Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%;   Drug: Placebo (Vehicle Gel)
14 Completed Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Lappa Arctium
15 Completed Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Azadirachta Indica
16 Completed Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Zingiber officinalis
17 Completed Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Adapalene-BPO Gel
18 Completed Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: RA-18C3
19 Unknown  Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II
Condition: Acne Vulgaris
Interventions: Drug: Benzoyl Peroxide 5% and Sulphur 2%;   Drug: Vehicle of Acnase
20 Completed A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: JNJ 10229570-AAA 1.2%;   Drug: JNJ 10229570-AAA 3.6%;   Drug: Color-matched vehicle containing 0 mg of JNJ 10229570-AAA

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years